bims-meglyc Biomed News
on Metabolic disorders affecting glycosylation
Issue of 2026–10–25
four papers selected by
Silvia Radenkovic, UMC Utrecht



  1. Cell Rep. 2026 Oct 19. pii: S2211-1247(26)01257-X. [Epub ahead of print]45(11): 118178
      N-glycosylation is essential for proteome integrity, yet the systemic roles of the cis-prenyltransferase (cis-PT) complex remain poorly defined. Using Caenorhabditis elegans, we demonstrate that this complex is a dual regulator of global lipid and lysosomal homeostasis. Mechanistically, NUS-1 physically associates with the core oligosaccharyltransferase (OST) complex to coordinate N-glycan transfer. Loss of NUS-1/DHDDS-1 triggers endoplasmic reticulum stress, lysosomal collapse, and systemic lipopenia. This lipid defect arises from impaired N-glycosylation of the SREBP cleavage-activating protein (SCAP). cis-PT deficiency causes unglycosylated SCAP to undergo massive degradation and absolute physical entrapment within the ER, preventing SREBP nuclear translocation and downstream lipid synthesis. Furthermore, pathogenic mutations cause dysfunction through distinct molecular mechanisms: pocket integrity disruption or catalytic impairment. These findings uncover an essential crosstalk between protein glycosylation and global lipid metabolism, providing a mechanistic framework for understanding the systemic pathophysiology of congenital disorders of glycosylation (CDG).
    Keywords:  CP: metabolism; CP: molecular biology; Caenorhabditis elegans; ER stress; N-glycosylation; NUS-1/DHDDS-1; SREBP; cis-prenyltransferase complex; lipid homeostasis; lysosomal homeostasis
    DOI:  https://doi.org/10.1016/j.celrep.2026.118178
  2. Int J Dev Neurosci. 2026 Oct;86(6): e70188
       BACKGROUND AND OBJECTIVES: NGLY1 (N-Glycanase 1) deficiency is an ultrarare autosomal recessive disorder affecting ~165 patients worldwide, characterized by developmental delay, hyperkinetic movement disorders and shortened life expectancy. Despite its severe neurological manifestations, comprehensive neuroimaging characterization has been limited to case reports and small descriptive studies. Our objective was to investigate alterations in brain morphology in patients with NGLY1 deficiency and determine whether these metrics associate with clinical phenotypes.
    METHODS: This case series analysed real-world MRI scans performed on 11 patients with molecularly diagnosed NGLY1 deficiency between 1999 and 2023 at sites across the globe. Ages ranged from 2 to 19 years at scan time (five female and six male). Cortical and subcortical morphology, including subcortical volume and cortical thickness, surface area, volume and curvature, was measured with three-dimensional T1-weighted magnetic resonance imaging (MRI) scans. Z scores were calculated using normative models from CentileBrain for patients > 3 years old or custom models for patients < 3 years old. Clinical phenotypes were matched to Human Phenotype Ontology codes.
    RESULTS: Sixteen scans from 11 patients met quality criteria for analysis. Both age groups (under and over 3 years old) showed significantly reduced subcortical volumes, particularly in bilateral thalamus and putamen. Younger patients demonstrated widespread reductions in cortical surface area, volume and curvature, indicating altered gyrification patterns. Older patients showed thinner dorsal and thicker ventral cortical regions with limited surface area reductions. Thalamic volume reduction in older patients correlated with gait disturbance, dysphagia and EEG abnormalities, with additional cortical associations with sleep and hearing abnormalities. Seizure presence in younger patients correlated with altered cortical thickness, surface area and curvature patterns.
    DISCUSSION: NGLY1 deficiency is associated with pervasive alterations in brain development affecting both subcortical and cortical morphology. Age-dependent patterns of cortical alterations indicate disrupted neurodevelopmental trajectories that may reflect impaired neuronal migration and/or altered synaptic pruning. Correlations with clinical variables suggest that these measures may serve as useful biomarkers for tracking disease progression and/or treatment efficacy. These findings provide a comprehensive neuroimaging characterization of NGLY1 Deficiency and establish a foundation for understanding brain structure-function relationships in this ultrarare disorder.
    Keywords:  NGLY1 deficiency; case series; neurogenetic disorder; structural neuroimaging
    DOI:  https://doi.org/10.1002/jdn.70188
  3. J Biol Chem. 2026 Oct 21. pii: S0021-9258(26)02560-3. [Epub ahead of print] 113688
      
    Keywords:  animal development; cancer; gangliosides; glycosylation; immune system; nervous system; polysialic acid; sialic acid; sialoglycoconjugates; sialome; sialylation
    DOI:  https://doi.org/10.1016/j.jbc.2026.113688
  4. Acc Chem Res. 2026 Oct 20. 59(20): 3336-3346
      O-GlcNAcylation is a ubiquitous post-translational modification across the mammalian proteome, yet determining how individual O-GlcNAcylation events control specific protein functions remains a central challenge. The O-GlcNAc cycle is governed by two enzymes: O-GlcNAc transferase (OGT), which installs O-GlcNAc, and O-GlcNAcase (OGA), which removes it. Because these enzymes act on thousands of proteins, conventional methods, such as pharmacological inhibition of OGT or OGA, produce broad cellular effects that are difficult to assign to individual substrates. This gap has motivated the development of targeted O-GlcNAcylation strategies, including genetically encoded and chemical biology tools, which have shown that O-GlcNAc can be selectively installed on defined proteins to interrogate protein-specific O-GlcNAc functions. This Account describes the development of O-GlcNAc TArgeting Chimeras, or OGTACs, as chemical tools for targeted O-GlcNAc installation. OGTACs are bifunctional molecules that can recruit OGT to a specific protein of interest. Specifically, an OGTAC consists of an OGT-engaging element, a linker, and a target-recognition motif, which together bring OGT into proximity with a selected substrate. Our studies show that chemically induced proximity can redirect OGT toward selected proteins, thereby creating targeted O-GlcNAc writing that can partially bypass TPR-domain-mediated substrate recognition under engineered recruitment conditions. A central lesson is that productive O-GlcNAc writing requires not only recruitment, but also proper ternary-complex formation and noninhibitory OGT engagement. Moreover, the target-recognition motif determines the targetable protein space and achievable selectivity of the platform. By linking local O-GlcNAc installation to changes in protein turnover, signaling, and transcriptional output, OGTACs provide a conceptual framework for using induced proximity to modulate protein functions.
    DOI:  https://doi.org/10.1021/acs.accounts.6c00453